Oxycodone during inpatient knee arthroplasty rehabilitation improves pain and recovery .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
A randomized trial of controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty
J Bone Joint Surg Am. 2001 Apr;83-A(4):572-659 patients were admitted for inpatient rehabilitation following unilateral total knee arthroplasty. These patients were randomized to receive OxyContin (controlled-release oxycodone) or a placebo, and patients in either group could receive on-request immediate release oxycodone. Patients were assessed for pain, changes in knee range of motion, quadriceps strength, the duration of the hospital stay for rehabilitation, and improvements in certain Functional Independence Measure scores during the first 8 physical therapy sessions. By the eighth session, the OxyContin group reported significantly less pain, greater range of motion and quadriceps strength, and faster discharge from hospital compared to the placebo group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics